Zogenix Inc.
Formerly SJ2 Therapeutics, Inc.
Funding rounds
5 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2010 | $15 M | No. 5 | $10 to $50 million | debt, options | SEC | |
| Sep 2009 | $71 M | No. 4 | $50 to $250 million | equity, options | SEC | |
| Jul 2009 | $3 M | No. 3 | $2 to $10 million | debt, options | SEC | |
| Jun 2009 | $3 M | No. 2 | $2 to $10 million | debt, options | SEC | |
| May 2009 | $3 M | No. 1 | $2 to $10 million | debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Zogenix Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2010).
SEC Form D · Jul 2010
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Jul 2010
That is all the official record says: Zogenix Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: its website does not allow automated readers.
Investors#
21 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Chicago Growth Management II, LLC | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Chicago Growth Management II, LP | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Chicago Growth Partners II L.P. | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Clarus Lifesciences I, L.P. | Fund or asset manager | not stated | not stated | Held Series A-1 and B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Clarus Ventures I, LLC | Venture capital | not stated | not stated | Held Series A-1 and B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Clarus Ventures I Management, L.P. | Venture capital | not stated | not stated | Held Series A-1 and B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Domain Parters VII L.P. | Fund or asset manager | not stated | not stated | Held Series A-1 and B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Domain Partners VI, L.P. | Fund or asset manager | not stated | not stated | Held Series A-1 preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| DP VI Associates, L.P. | Fund or asset manager | not stated | not stated | Held Series A-1 preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| DP VII Associates LP | Fund or asset manager | not stated | not stated | Held Series A-1 and B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Roger Hawley | Person | not stated | not stated | Held Series A-1 preferred stock, director (Form 3, 2010) | SEC Form 3 |
| Scale Venture Management II, LLC | Venture capital | not stated | not stated | Held Series A-1 and B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Scale Venture Partners II, LP | Venture capital | not stated | not stated | Held Series A-1 and B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Thomas, McNerney & Partners II, LLC | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Thomas, McNerney & Partners II L.P. | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Thomas, McNerney & Partners, LLC | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| Thomas Mcnerney & Partners LP | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| TMP Associates II LP | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| TMP Associates LP | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| TMP Nominee II, LLC | Other | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
| TMP Nominee, LLC | Other | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2010) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 14 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Ann D. Rhoads | Executive officer | Jul 2010 |
| Cynthia Y. Robinson | Executive officer | Jul 2010 |
| J.D. Y. Haldeman | Executive officer | Jul 2010 |
| Roger L. Hawley | Executive officer | Jul 2010 |
| Stephen J. Farr | Executive officer | Jul 2010 |
| David W. Nassif | Executive officer | Dec 2009 |
| J.D. Haldeman | Executive officer | Jul 2009 |
| Alex C. Zisson | Director | Jul 2010 |
| Arda M. Minocherhomjee | Director | Jul 2010 |
| Cam L. Garner | Director | Jul 2010 |
| Erle T. Mast | Director | Jul 2010 |
| James C. Blair | Director | Jul 2010 |
| Ken M. Haas | Director | Jul 2010 |
| Kurt C. Wheeler | Director | Jul 2010 |
| Louis C. Bock | Director | Jul 2010 |
| Roger L. Hawley | Director | Jul 2010 |
| Stephen J. Farr | Director | Jul 2010 |
| Arda M. Minocherhomjee, Ph.D. | Director | Dec 2009 |
| Ken T. Haas | Director | Dec 2009 |
| Alex Zisson | Director | Jul 2009 |
| Cam Garner | Director | May 2009 |
About
Company in Emeryville, United States.